nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—CYP2D6—Alzheimer's disease	0.513	1	CbGaD
Alprenolol—CYP2D6—Rivastigmine—Alzheimer's disease	0.176	0.432	CbGbCtD
Alprenolol—CYP2D6—Donepezil—Alzheimer's disease	0.141	0.345	CbGbCtD
Alprenolol—CYP2D6—Galantamine—Alzheimer's disease	0.0907	0.223	CbGbCtD
Alprenolol—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00156	0.277	CbGeAlD
Alprenolol—Betaxolol—CYP2D6—Alzheimer's disease	0.000587	0.177	CrCbGaD
Alprenolol—Bisoprolol—CYP2D6—Alzheimer's disease	0.000567	0.17	CrCbGaD
Alprenolol—Acebutolol—CYP2D6—Alzheimer's disease	0.000537	0.161	CrCbGaD
Alprenolol—Oxprenolol—CYP2D6—Alzheimer's disease	0.000533	0.16	CrCbGaD
Alprenolol—ADRB1—forebrain—Alzheimer's disease	0.000475	0.0843	CbGeAlD
Alprenolol—Metoprolol—CYP2D6—Alzheimer's disease	0.000454	0.136	CrCbGaD
Alprenolol—ADRB1—telencephalon—Alzheimer's disease	0.000437	0.0775	CbGeAlD
Alprenolol—Pindolol—CYP2D6—Alzheimer's disease	0.00042	0.126	CrCbGaD
Alprenolol—HTR1A—forebrain—Alzheimer's disease	0.000407	0.0723	CbGeAlD
Alprenolol—HTR1A—telencephalon—Alzheimer's disease	0.000375	0.0665	CbGeAlD
Alprenolol—ADRB1—nervous system—Alzheimer's disease	0.000258	0.0458	CbGeAlD
Alprenolol—ADRB1—central nervous system—Alzheimer's disease	0.000248	0.0441	CbGeAlD
Alprenolol—Propranolol—CYP2D6—Alzheimer's disease	0.000229	0.0688	CrCbGaD
Alprenolol—CYP2D6—forebrain—Alzheimer's disease	0.000221	0.0393	CbGeAlD
Alprenolol—HTR1A—nervous system—Alzheimer's disease	0.000221	0.0393	CbGeAlD
Alprenolol—HTR1A—central nervous system—Alzheimer's disease	0.000213	0.0378	CbGeAlD
Alprenolol—HTR1A—cerebellum—Alzheimer's disease	0.000208	0.0369	CbGeAlD
Alprenolol—CYP2D6—telencephalon—Alzheimer's disease	0.000203	0.0361	CbGeAlD
Alprenolol—ADRB1—brain—Alzheimer's disease	0.000197	0.035	CbGeAlD
Alprenolol—HTR1A—brain—Alzheimer's disease	0.000169	0.03	CbGeAlD
Alprenolol—CYP2D6—nervous system—Alzheimer's disease	0.00012	0.0213	CbGeAlD
Alprenolol—CYP2D6—central nervous system—Alzheimer's disease	0.000116	0.0205	CbGeAlD
Alprenolol—CYP2D6—cerebellum—Alzheimer's disease	0.000113	0.0201	CbGeAlD
Alprenolol—CYP2D6—brain—Alzheimer's disease	9.18e-05	0.0163	CbGeAlD
Alprenolol—CYP2D6—Metabolism—PLD3—Alzheimer's disease	3.83e-05	0.000539	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NCSTN—Alzheimer's disease	3.82e-05	0.000537	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	3.81e-05	0.000535	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	3.8e-05	0.000535	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	3.8e-05	0.000535	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NGFR—Alzheimer's disease	3.77e-05	0.00053	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CREB1—Alzheimer's disease	3.74e-05	0.000526	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LRP1—Alzheimer's disease	3.72e-05	0.000524	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	3.72e-05	0.000523	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	3.72e-05	0.000523	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADAM10—Alzheimer's disease	3.68e-05	0.000517	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	3.67e-05	0.000517	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL2—Alzheimer's disease	3.66e-05	0.000515	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GAL—Alzheimer's disease	3.64e-05	0.000511	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GFAP—Alzheimer's disease	3.64e-05	0.000511	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	3.54e-05	0.000498	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—S100B—Alzheimer's disease	3.48e-05	0.000489	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ND1—Alzheimer's disease	3.42e-05	0.000481	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	3.35e-05	0.000471	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF2—Alzheimer's disease	3.31e-05	0.000466	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.3e-05	0.000464	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	3.28e-05	0.000461	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	3.24e-05	0.000456	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.23e-05	0.000454	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—A2M—Alzheimer's disease	3.2e-05	0.000451	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1R—Alzheimer's disease	3.2e-05	0.00045	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	3.17e-05	0.000446	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.16e-05	0.000444	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	3.13e-05	0.00044	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PSEN2—Alzheimer's disease	3.1e-05	0.000436	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LPL—Alzheimer's disease	3.07e-05	0.000432	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.06e-05	0.000431	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	3.06e-05	0.000431	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MEF2C—Alzheimer's disease	3.04e-05	0.000428	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	3e-05	0.000422	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	3e-05	0.000421	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR5—Alzheimer's disease	2.99e-05	0.000421	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	2.99e-05	0.00042	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PRKCG—Alzheimer's disease	2.98e-05	0.00042	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	2.97e-05	0.000417	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	2.93e-05	0.000413	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.93e-05	0.000412	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	2.92e-05	0.000411	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NGF—Alzheimer's disease	2.91e-05	0.000409	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	2.9e-05	0.000408	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	2.88e-05	0.000405	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PRKCG—Alzheimer's disease	2.87e-05	0.000403	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NPY—Alzheimer's disease	2.86e-05	0.000402	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	2.84e-05	0.0004	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IAPP—Alzheimer's disease	2.84e-05	0.000399	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR5—Alzheimer's disease	2.83e-05	0.000398	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	2.82e-05	0.000396	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.78e-05	0.000391	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	2.78e-05	0.000391	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—Alzheimer's disease	2.77e-05	0.000389	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CRH—Alzheimer's disease	2.75e-05	0.000388	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	2.73e-05	0.000384	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	2.72e-05	0.000383	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR5—Alzheimer's disease	2.72e-05	0.000382	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.72e-05	0.000382	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	2.68e-05	0.000378	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	2.68e-05	0.000377	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	2.67e-05	0.000376	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	2.66e-05	0.000374	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	2.66e-05	0.000374	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	2.63e-05	0.000369	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	2.62e-05	0.000368	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NPS—Alzheimer's disease	2.61e-05	0.000367	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	2.6e-05	0.000366	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	2.6e-05	0.000366	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	2.6e-05	0.000366	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	2.6e-05	0.000366	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	2.59e-05	0.000365	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	2.58e-05	0.000363	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CALM1—Alzheimer's disease	2.58e-05	0.000363	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LEP—Alzheimer's disease	2.57e-05	0.000362	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—Alzheimer's disease	2.57e-05	0.000362	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—F2—Alzheimer's disease	2.57e-05	0.000361	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTK2B—Alzheimer's disease	2.56e-05	0.00036	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CAV1—Alzheimer's disease	2.55e-05	0.000359	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	2.55e-05	0.000358	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	2.55e-05	0.000358	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	2.55e-05	0.000358	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	2.54e-05	0.000357	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	2.54e-05	0.000357	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	2.53e-05	0.000355	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GAB2—Alzheimer's disease	2.49e-05	0.00035	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NTRK2—Alzheimer's disease	2.49e-05	0.00035	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SST—Alzheimer's disease	2.49e-05	0.00035	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	2.48e-05	0.000349	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CALM1—Alzheimer's disease	2.48e-05	0.000349	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GSK3A—Alzheimer's disease	2.47e-05	0.000347	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ESR1—Alzheimer's disease	2.46e-05	0.000346	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	2.44e-05	0.000343	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APP—Alzheimer's disease	2.43e-05	0.000342	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—F2—Alzheimer's disease	2.43e-05	0.000341	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	2.4e-05	0.000337	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	2.38e-05	0.000335	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOTCH1—Alzheimer's disease	2.37e-05	0.000334	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	2.34e-05	0.00033	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—F2—Alzheimer's disease	2.33e-05	0.000328	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLCB1—Alzheimer's disease	2.29e-05	0.000322	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	2.23e-05	0.000314	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GSK3B—Alzheimer's disease	2.23e-05	0.000313	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	2.22e-05	0.000312	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CREB1—Alzheimer's disease	2.21e-05	0.000311	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPI1—Alzheimer's disease	2.2e-05	0.00031	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CHAT—Alzheimer's disease	2.2e-05	0.00031	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INS—Alzheimer's disease	2.2e-05	0.000309	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	2.19e-05	0.000308	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	2.18e-05	0.000307	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	2.17e-05	0.000306	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	2.17e-05	0.000306	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL2—Alzheimer's disease	2.16e-05	0.000304	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NGFR—Alzheimer's disease	2.14e-05	0.000301	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	2.14e-05	0.0003	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1—Alzheimer's disease	2.13e-05	0.000299	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	2.13e-05	0.000299	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CREB1—Alzheimer's disease	2.12e-05	0.000299	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOB—Alzheimer's disease	2.11e-05	0.000297	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADAM10—Alzheimer's disease	2.09e-05	0.000294	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL2—Alzheimer's disease	2.08e-05	0.000292	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	2.06e-05	0.00029	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	2.03e-05	0.000286	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	2.02e-05	0.000284	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—S100B—Alzheimer's disease	1.97e-05	0.000278	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	1.97e-05	0.000276	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.96e-05	0.000276	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOS3—Alzheimer's disease	1.93e-05	0.000271	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	1.92e-05	0.00027	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	1.9e-05	0.000267	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF2—Alzheimer's disease	1.88e-05	0.000264	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.86e-05	0.000261	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	1.82e-05	0.000256	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1R—Alzheimer's disease	1.82e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	1.81e-05	0.000254	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	1.78e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	1.77e-05	0.000249	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	1.77e-05	0.000248	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LPL—Alzheimer's disease	1.74e-05	0.000245	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	1.73e-05	0.000244	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MEF2C—Alzheimer's disease	1.73e-05	0.000243	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	1.73e-05	0.000243	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ACHE—Alzheimer's disease	1.71e-05	0.00024	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PRKCG—Alzheimer's disease	1.69e-05	0.000238	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	1.69e-05	0.000237	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	1.69e-05	0.000237	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	1.68e-05	0.000236	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.65e-05	0.000232	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NGF—Alzheimer's disease	1.65e-05	0.000232	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	1.64e-05	0.000231	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	1.64e-05	0.000231	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CASP3—Alzheimer's disease	1.64e-05	0.00023	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—Alzheimer's disease	1.63e-05	0.000229	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	1.61e-05	0.000226	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR5—Alzheimer's disease	1.61e-05	0.000226	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ENO1—Alzheimer's disease	1.6e-05	0.000225	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	1.6e-05	0.000225	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—Alzheimer's disease	1.57e-05	0.000221	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	1.53e-05	0.000216	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	1.53e-05	0.000215	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	1.53e-05	0.000215	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	1.51e-05	0.000213	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK8—Alzheimer's disease	1.5e-05	0.000212	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—Alzheimer's disease	1.5e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	1.5e-05	0.000211	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	1.49e-05	0.00021	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	1.49e-05	0.00021	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—BCHE—Alzheimer's disease	1.49e-05	0.000209	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	1.48e-05	0.000208	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	1.47e-05	0.000206	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	1.46e-05	0.000205	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	1.46e-05	0.000205	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	1.46e-05	0.000205	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	1.45e-05	0.000204	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	1.44e-05	0.000203	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	1.43e-05	0.000201	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.41e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	1.41e-05	0.000198	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	1.4e-05	0.000197	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	1.39e-05	0.000196	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—VEGFA—Alzheimer's disease	1.39e-05	0.000195	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.38e-05	0.000194	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—F2—Alzheimer's disease	1.38e-05	0.000194	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	1.36e-05	0.000191	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.35e-05	0.00019	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	1.32e-05	0.000186	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	1.31e-05	0.000185	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	1.3e-05	0.000184	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	1.29e-05	0.000182	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	1.28e-05	0.000181	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	1.28e-05	0.000181	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	1.28e-05	0.00018	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	1.27e-05	0.000179	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.26e-05	0.000178	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	1.26e-05	0.000177	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	1.26e-05	0.000177	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	1.25e-05	0.000176	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—Alzheimer's disease	1.25e-05	0.000176	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	1.23e-05	0.000174	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	1.23e-05	0.000173	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	1.21e-05	0.00017	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	1.17e-05	0.000165	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	1.17e-05	0.000164	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	1.14e-05	0.000161	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	1.12e-05	0.000157	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.09e-05	0.000154	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.07e-05	0.00015	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	1.05e-05	0.000148	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	9.8e-06	0.000138	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	9.71e-06	0.000137	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	9.65e-06	0.000136	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	9.61e-06	0.000135	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	9.6e-06	0.000135	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	9.59e-06	0.000135	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	9.5e-06	0.000134	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	9.44e-06	0.000133	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	9.38e-06	0.000132	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	9.29e-06	0.000131	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	9.23e-06	0.00013	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	8.98e-06	0.000126	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—Alzheimer's disease	8.95e-06	0.000126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	8.93e-06	0.000126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	8.9e-06	0.000125	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	8.86e-06	0.000125	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	8.86e-06	0.000125	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	8.73e-06	0.000123	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	8.71e-06	0.000122	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	8.54e-06	0.00012	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	8.51e-06	0.00012	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	8.24e-06	0.000116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	8.06e-06	0.000113	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	7.88e-06	0.000111	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	7.79e-06	0.00011	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—Alzheimer's disease	7.64e-06	0.000108	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	7.56e-06	0.000106	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	7.4e-06	0.000104	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	7.24e-06	0.000102	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	6.7e-06	9.43e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	6.23e-06	8.76e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	6.13e-06	8.62e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	6.09e-06	8.57e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	5.96e-06	8.38e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	5.7e-06	8.02e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	5.58e-06	7.84e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	5.45e-06	7.67e-05	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	5.26e-06	7.4e-05	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	5.14e-06	7.24e-05	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	5.03e-06	7.08e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	3.08e-06	4.33e-05	CbGpPWpGaD
